Login to Your Account



CV Therapeutics Begins Second Phase III Trial Of Regadenoson

By Kim Coghill


Tuesday, April 27, 2004
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription